Dr Marie Fisk
Marie is a dual trainee in clinical pharmacology and respiratory medicine. She is a clinical lecturer in the Department of Medicine as part of the ‘Experimental Medicine Initiative’. Her research interests are to improve the poor health burden associated with respiratory disease, for example through new medicines. She is currently in flexible training and helps organise the Springboard conference for medical trainees returning to training after time out.
Dr James Goodman
James is a dual trainee in Clinical Pharmacology and General Medicine. Following his ST5 year, he started an ‘Experimental Medicine Initiative’ funded clinical PhD at the University of Cambridge, looking at the cardiovascular effects of novel drugs for diabetes (supervised by Professor Ian Wilkinson). He is an expert member of the Central Cambridge Ethics Committee and a British Pharmacological Society) trainee representative for Cambridge.
Dr Emma Hodson
Emma is an Academic Clinical Lecturer in Clinical Pharmacology. Her research interests are in the role of hypoxia in neurogenic hypertension and phaeochromocytoma / paraganglioma.
Dr Bernadette Jenner
Bernie is a is a dual trainee in Clinical Pharmacology and General Medicine. Her clinical interests are Obstetric Medicine and management of hypertension. She is the Physician Trainee representative for the McDonald Obstetric Medicine Society and a Junior Editor for the Obstetric Medicine journal. She is also a British Pharmacology society registrar representative and enjoys teaching about medical problems in pregnancy.
Dr Spoorthy Kulkarni
Spoorthy is a trainee in Clinical Pharmacology and Therapeutics. She is interested in chronic cardiovascular risk management, teaching medical students, clinical trial designs and various aspects of drug development. She is actively contributes to a number of ongoing clinical trials.
Ing is a dual trainee in clinical pharmacology and general internal medicine. She is interested in running clinical trials and has actively take part in different trials especially during the pandemic. She has an interest in drug development, and is excited about the newer therapeutic options in reducing the burden of cardiovascular diseases.
Dr Douglas Maslin
Douglas is a dual trainee in Clinical Pharmacology and Dermatology – one of three nationally. He is particularly interested in improving the way medications are used within dermatology, and in both early- and late- phase clinical trials. He is a fellow and steering committee member of the UK Dermatology Clinical Trials Network; and is also involved with teaching and the running of medical exams at the University of Cambridge. He is an expert member of the Cambridge Central Research Ethics Committee and the trainee representative for Clinical Pharmacology in the East of England.
Dr Stephen Smith
Steve is a dual trainee in clinical pharmacology and dermatology – the first of three nationally. He is currently undertaking a period of out of program research funded by the MRC. He is a current member of (1) NICE technology appraisals committee B, (2) the British Association of Dermatologists research sub-committee, and (3) the steering committee of translational medicine in dermatology (TREND). His research involves computational modelling and bioinformatics, focusing on cancer biology.